What's breaking now, across thousands of outlets.
AstraZeneca has withdrawn its European marketing application for a monoclonal antibody in a subset of amyloidosis patients. The candidate had previously failed two late-stage studies in a broader population, but the drugmaker then said that ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Middle-aged men should undergo regular screening for prostate cancer, the American Cancer Society said Thursday in a major change to its guidelines.
Middle-aged men should undergo regular screening for prostate cancer, the American Cancer Society said Thursday in a major change to its guidelines.
The COVID-19 pandemic coincided with one of the most dramatic swings in homicide in modern American history.
The purchase of the $500 million Missouri nonprofit includes a 10-year, $200 million capital commitment, and is expected to bring Ardent at least $30 million annual EBITDA by its third year.
Gavi and partners have intensified a grassroots immunisation campaign in Abuja to identify and vaccinate zero-dose children in underserved communities.
Final results from the phase 2 PECATI clinical trial demonstrate encouraging long-term survival outcomes with the combination of lenvatinib and pembrolizumab in patients with previously treated…
